Ebola is rare, deadly and has multiple variations. There is a vaccine for the Zaire type, now trials for another are underway ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good ...

The first participants have been vaccinated with an investigational Ebola Sudan vaccine candidate provided by IAVI, a nonprofit scientific ...

Test results on the sick people are pending, and a top WHO official said the outbreak response is proceeding rapidly.

Today Sierra Leone is embarking on a nationwide campaign with the rVSV-ZEBOV vaccine, trademarked as Ervebo. The Ervebo vaccine, developed by Merck, is a single-dose vaccine. It works by using a ...

Makerere University, the Uganda Virus Research Institute and the WHO got the Ebola vaccine trial ready for dosing in just ...

As Ebola swept through Sierra Leone in 2014, there were no approved vaccines against the disease. In 2019, the WHO prequalified the Ervebo vaccine and Gavi formally approved the establishment of a ...

In its last outbreak, more than two years ago, Uganda saw 164 cases and 55 confirmed deaths from Ebola. Uganda announced ...

The new vaccine – known during its development as V920 (rVSVΔG-ZEBOV-GP) – will be distributed under the Ervebo brand name if approved by the EMA for active immunisation of individuals aged ...

Today Sierra Leone is embarking on a nationwide campaign with the rVSV-ZEBOV vaccine, trademarked as Ervebo. The campaign will target 20,000 frontline workers in 16 districts. These include ...

Today Sierra Leone is embarking on a nationwide campaign with the rVSV-ZEBOV vaccine, trademarked as Ervebo. The campaign will target 20,000 frontline workers in 16 districts. These include healthcare ...